TDH3-STE2Δ(301-431)-BFP-CIBN-MKII-eLOV-TEVcs(ENLYFQ/M)LexAVP16-tCYC
(Plasmid
#135465)
-
PurposeMembrane-anchored TF used for yeast directed evolution of TEV protease
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 135465 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRG205
-
Backbone manufacturerRobert Gnuegge
- Backbone size w/o insert (bp) 5660
- Total vector size (bp) 9565
-
Vector typeYeast Expression
-
Selectable markersLEU2
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSTE2Δ(301-431)-BFP-CIBN-MKII-eLOV-TEVcs(ENLYFQ/M)-LexAVP16
-
SpeciesSynthetic
-
Insert Size (bp)3915
- Promoter TDH3
-
Tag
/ Fusion Protein
- BFP, flag
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer GGTAGGTATTGATTGTAATTCTGTAAATC
- 3′ sequencing primer CTTCAGGTTGTCTAACTCCTTCCTTTTC (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
For integration in yeast, linearize plasmid with AscI.
The reporter genes associated with this construct are #58432, #58433 and #58434 published in: Nucleic Acids Res. 42, e130–e130 (2014)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
TDH3-STE2Δ(301-431)-BFP-CIBN-MKII-eLOV-TEVcs(ENLYFQ/M)LexAVP16-tCYC was a gift from Alice Ting (Addgene plasmid # 135465 ; http://n2t.net/addgene:135465 ; RRID:Addgene_135465) -
For your References section:
Directed evolution improves the catalytic efficiency of TEV protease. Sanchez MI, Ting AY. Nat Methods. 2019 Dec 9. pii: 10.1038/s41592-019-0665-7. doi: 10.1038/s41592-019-0665-7. 10.1038/s41592-019-0665-7 PubMed 31819267